Aurora Cannabis (ACB) Cash & Current Investments (2017 - 2025)
Aurora Cannabis (ACB) reported Cash & Current Investments of $77.8 million for Q4 2025, down 46.77% year-over-year from $146.1 million in Q4 2024, and down 24.6% quarter-over-quarter from $103.1 million in Q3 2025.
Aurora Cannabis (ACB) Cash & Current Investments (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Cash & Current Investments data on file, last reported at $77.8 million in Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $77.8 million, down 46.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $77.8 million (down 46.77% YoY), and the FY2025 annual result was $129.2 million, down 22.56% from the prior year.
- Cash & Current Investments slipped to $77.8 million in Q4 2025 per ACB's latest filing, from $103.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $376.8 million in Q1 2021 and troughed at $77.8 million in Q4 2025.
- A 5-year average of $219.3 million and a median of $182.9 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2021 and 2023: Cash & Current Investments surged 175.7% in 2021, then plunged 48.98% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $309.0 million in 2021, then retreated by 0.93% to $306.1 million in 2022, then slipped by 23.83% to $233.2 million in 2023, then tumbled by 37.35% to $146.1 million in 2024, then tumbled by 46.77% to $77.8 million in 2025.
- Business Quant data shows ACB's Cash & Current Investments at $77.8 million in Q4 2025, $103.1 million in Q3 2025, and $134.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.77 Mn |
| Sep 30, 2025 | 103.14 Mn |
| Jun 30, 2025 | 134.26 Mn |
| Mar 31, 2025 | 129.16 Mn |
| Dec 31, 2024 | 146.10 Mn |
| Sep 30, 2024 | 127.73 Mn |
| Jun 30, 2024 | 149.80 Mn |
| Mar 31, 2024 | 103.99 Mn |
| Dec 31, 2023 | 233.20 Mn |
| Sep 30, 2023 | 176.75 Mn |
| Jun 30, 2023 | 175.09 Mn |
| Mar 31, 2023 | 189.06 Mn |
| Dec 31, 2022 | 306.15 Mn |
| Sep 30, 2022 | 329.33 Mn |
| Jun 30, 2022 | 343.14 Mn |
| Mar 31, 2022 | 308.05 Mn |
| Dec 31, 2021 | 309.01 Mn |
| Sep 30, 2021 | 322.28 Mn |
| Jun 30, 2021 | 345.92 Mn |
| Mar 31, 2021 | 376.82 Mn |